US President Donald Trump announced a 59% reduction in pharmaceutical prices in the US, causing global pharmaceutical stocks to plummet. The announcement follows a report revealing that American consumers pay more than three times as much for prescription drugs compared to other countries. This comes in addition to Trump’s previous announcement of upcoming tariffs on pharmaceuticals, posing a double blow to global pharmaceutical companies.
Original Article: Read More
Auto-posted at: 2025-05-12 21:03:30